Lithium Carbonate Tablet, Extended Release
Product Images NDC 0054-0020

1 FDA label image from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 0054-0020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100-count Bottle Label (Lithium Er 450mg)

100-count Bottle Label (Lithium Er 450mg)
Label for Lithium Carbonate Extended-release Tablets USP, 450 mg, in a 100-tablet package. The label shows dosage strength clearly and includes storage instructions to protect from moisture and keep at 20° to 25°C. Distributed by Hikma Pharmaceuticals USA Inc., this oral prescription drug is packaged in a child-resistant container. The NDC is 0054-0020-25.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.